Press Releases May 13, 2026 04:05 PM

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.19 Per Share

Hawkins, Inc. declares quarterly cash dividend of $0.19 per share payable June 12, 2026

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
HWKN

Hawkins, Inc., a leading water treatment and specialty ingredients company, announced a quarterly cash dividend of $0.19 per share, payable on June 12, 2026, to shareholders of record as of May 29, 2026. The company has consistently paid dividends since 1985, reflecting financial stability and commitment to shareholder returns.

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.19 Per Share
HWKN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Hawkins, Inc. declared a quarterly cash dividend of $0.19 per share.
  • Dividend payable on June 12, 2026, to shareholders of record on May 29, 2026.
  • The company has a long history of dividend payments since 1985, indicating stable financial health.
  • Hawkins operates in water treatment, food & health sciences, and industrial solutions sectors, impacting these industries.

ROSEVILLE, Minn., May 13, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on May 13, 2026, declared a quarterly cash dividend of $0.19 per share, payable June 12, 2026, to shareholders of record at the close of business on May 29, 2026. Hawkins has consistently paid out a dividend since 1985.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 66 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and has approximately 1,200 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Contact:        
Jeffrey P. Oldenkamp        
Executive Vice President and Chief Financial Officer
612/331-6910                
ir@hawkinsinc.com


Risks

  • Future dividend payments depend on company profitability and cash flow, which could be affected by market conditions.
  • Operational risks in water treatment and specialty ingredients sectors may impact financial performance.
  • Economic downturns could reduce demand in Hawkins' key markets, potentially influencing dividend stability.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026